Trial
NCT00830037
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
Phase IVTERMINATEDSAFETYConfidence: HIGH
Sponsor
Indiana University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Chronic Kidney Disease
Intervention
IV Iron
Why stopped
Terminated by the DSMB based on low chance of finding differences in mGFR slopes, but higher risk of serious adverse events in the IV iron group (aIRR = 1.60)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-21